VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

CinCor Pharma

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 77 out of 100

  • Biotech & therapeutics
Status
Acquiredas of 2026-09-17Source (opens in a new tab)
Business model
B2B
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

CinCor (CINC) is a clinical-stage biopharmaceutical company with a mission to advance clinical candidates in the area of cardiovascular disease. Acquired by AstraZeneca in 2023.

About the company

Status notes
Acquired by AstraZeneca in 2023.

Exit

Acquisition
2023
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy